Introduction: Stroke etiology could influence treatment decisions. This study aimed to evaluate the efficacy and safety of bridging therapy (BT) compared to direct endovascular treatment (EVT) in patients with basilar artery occlusion (BAO), stratified by stroke subtype. Methods: Data were collected from the PERSIST multicenter retrospective registry, enrolling patients with acute symptomatic BAO treated with EVT. Stroke subtypes were classified based on the TOAST criteria into large artery atherosclerosis (LAA), cardioembolism (CE), and other causes (Others). A propensity score-matched analysis was performed to compare outcomes between patients receiving BT and those undergoing direct EVT. The primary outcome was a favorable functional outcome (mRS 0–3) at 90 days. Secondary outcomes included functional independence (mRS 0–2), 90-day mortality, and symptomatic intracranial hemorrhage (sICH). Results: A total of 577 BAO patients were included, with 376 patients classified as LAA, 119 as CE, and 82 as other causes. In the LAA subgroup, BT was associated with a higher likelihood of favorable outcomes compared to EVT (53.8% vs. 34.4%; OR: 1.29; 95% CI: 1.02–1.65). In the CE subgroup, BT was associated with an increased likelihood of functional independence (mRS 0–2) at 90 days (OR: 1.57; 95% CI: 1.01–2.51). No significant increase in the risk of sICH or 90-day mortality was observed in any of the subgroups following BT. Conclusion: BT appears to be an effective and safe treatment strategy in patients with BAO, particularly in those with LAA and CE etiologies. BT was associated with better functional outcomes compared to direct EVT without increasing the risk of hemorrhagic complications. These findings suggest that stroke subtype should be considered when tailoring treatment strategies for BAO patients. Further prospective randomized trials are needed to confirm these results.

Journal Section:
Clinical Research in Stroke
Keywords:
Stroke, Endovascular treatment, Cardioembolism, Atherosclerosis, Thrombolysis
1.
Lindsberg
PJ
,
Sairanen
T
,
Nagel
S
,
Salonen
O
,
Silvennoinen
H
,
Strbian
D
.
Recanalization treatments in basilar artery occlusion-systematic analysis
.
Eur Stroke J
.
2016
;
1
:
41
–
50
.
Google Scholar
PubMed
 
2.
Nguyen
TN
,
Strbian
D
.
Endovascular therapy for stroke due to basilar artery occlusion: a BASIC challenge at best
.
Stroke
.
2021
;
52
(
10
):
3410
–
3
.
Google Scholar
PubMed
 
3.
Jovin
TG
,
Li
C
,
Wu
L
,
Wu
C
,
Chen
J
,
Jiang
C
, et al.
Trial of thrombectomy 6 to 24 hours after stroke due to basilar-artery occlusion
.
N Engl J Med
.
2022
;
387
(
15
):
1373
–
84
.
Google Scholar
PubMed
 
4.
Tao
C
,
Nogueira
RG
,
Zhu
Y
,
Sun
J
,
Han
H
,
Yuan
G
, et al.
Trial of endovascular treatment of acute basilar-artery occlusion
.
N Engl J Med
.
2022
;
387
(
15
):
1361
–
72
.
Google Scholar
PubMed
 
5.
Markus
HS
,
van der Worp
HB
,
Rothwell
PM
.
Posterior circulation ischaemic stroke and transient ischaemic attack: diagnosis, investigation, and secondary prevention
.
Lancet Neurol
.
2013
;
12
(
10
):
989
–
98
.
Google Scholar
PubMed
 
6.
Labropoulos
N
,
Nandivada
P
,
Bekelis
K
.
Stroke of the posterior cerebral circulation
.
Int Angiol
.
2011
;
30
(
2
):
105
–
14
.
Google Scholar
PubMed
 
7.
Suzuki
K
,
Matsumaru
Y
,
Takeuchi
M
,
Morimoto
M
,
Kanazawa
R
,
Takayama
Y
, et al.
Effect of mechanical thrombectomy without vs with intravenous thrombolysis on functional outcome among patients with acute ischemic stroke: the skip randomized clinical trial
.
JAMA
.
2021
;
325
(
3
):
244
–
53
.
Google Scholar
PubMed
 
8.
LeCouffe
NE
,
Kappelhof
M
,
Treurniet
KM
,
Rinkel
LA
,
Bruggeman
AE
,
Berkhemer
OA
, et al.
A randomized trial of intravenous alteplase before endovascular treatment for stroke
.
N Engl J Med
.
2021
;
385
(
20
):
1833
–
44
.
Google Scholar
PubMed
 
9.
Yang
P
,
Zhang
Y
,
Zhang
L
,
Zhang
Y
,
Treurniet
KM
,
Chen
W
, et al.
Endovascular thrombectomy with or without intravenous alteplase in acute stroke
.
N Engl J Med
.
2020
;
382
(
21
):
1981
–
93
.
Google Scholar
PubMed
 
10.
Zi
W
,
Qiu
Z
,
Li
F
,
Sang
H
,
Wu
D
,
Luo
W
, et al.
Effect of endovascular treatment alone vs intravenous alteplase plus endovascular treatment on functional independence in patients with acute ischemic stroke: the DEVT randomized clinical trial
.
JAMA
.
2021
;
325
(
3
):
234
–
43
.
Google Scholar
PubMed
 
11.
Nappini
S
,
Arba
F
,
Pracucci
G
,
Saia
V
,
Caimano
D
,
Limbucci
N
, et al.
Bridging versus direct endovascular therapy in basilar artery occlusion
.
J Neurol Neurosurg Psychiatry
.
2021
;
92
(
9
):
956
–
62
.
Google Scholar
PubMed
 
12.
Nie
X
,
Wang
D
,
Pu
Y
,
Wei
Y
,
Lu
Q
,
Yan
H
, et al.
Endovascular treatment with or without intravenous alteplase for acute ischaemic stroke due to basilar artery occlusion
.
Stroke Vasc Neurol
.
2022
;
7
(
3
):
190
–
9
.
Google Scholar
PubMed
 
13.
Siow
I
,
Tan
BYQ
,
Lee
KS
,
Ong
N
,
Toh
E
,
Gopinathan
A
, et al.
Bridging thrombolysis versus direct mechanical thrombectomy in stroke due to basilar artery occlusion
.
J Stroke
.
2022
;
24
(
1
):
128
–
37
.
Google Scholar
PubMed
 
14.
Zheng
W
,
Lei
H
,
Lin
X
,
Liu
N
,
Tang
Y
,
Wu
J
, et al.
Intravenous thrombolysis prior to endovascular treatment for acute ischemic stroke: a meta-analysis
.
Neurol Sci
.
2022
;
43
(
10
):
5993
–
6002
.
Google Scholar
PubMed
 
15.
Zhang
P
,
Li
H
,
Wang
J
,
Zhang
F
,
Xiao
L
,
Fang
Y
, et al.
Sex differences in outcomes after endovascular treatment of patients with vertebrobasilar artery occlusion
.
Eur Stroke J
.
2023
;
8
(
2
):
566
–
74
.
Google Scholar
PubMed
 
16.
Xiao
L
,
Gu
M
,
Lu
Y
,
Xu
P
,
Wang
J
,
Lan
W
, et al.
Influence of renal impairment on clinical outcomes after endovascular recanalization in vertebrobasilar artery occlusions
.
J Neurointerv Surg
.
2022
;
14
(
11
):
1077
–
83
.
Google Scholar
PubMed
 
17.
Zhang
P
,
Xu
P
,
Duan
Z
,
Zhang
F
,
Fang
Y
,
Yan
D
, et al.
Effects of admission systemic inflammatory indicators on clinical outcomes in patients with vertebrobasilar artery occlusion: insight from the PERSIST registry
.
J Neurointerv Surg
.
2023
;
15
(
e2
):
e270
–
6
.
Google Scholar
PubMed
 
18.
Adams
HP
,
Bendixen
BH
,
Kappelle
LJ
,
Biller
J
,
Love
BB
,
Gordon
DL
, et al.
Classification of subtype of acute ischemic stroke. Definitions for use in a multicenter clinical trial. TOAST. Trial of Org 10172 in Acute Stroke Treatment
.
Stroke
.
1993
;
24
(
1
):
35
–
41
.
Google Scholar
PubMed
 
19.
Higashida
RT
,
Furlan
AJ
,
Roberts
H
,
Tomsick
T
,
Connors
B
,
Barr
J
, et al.
Trial design and reporting standards for intra-arterial cerebral thrombolysis for acute ischemic stroke
.
Stroke
.
2003
;
34
(
8
):
e109
–
37
.
Google Scholar
PubMed
 
20.
Singer
OC
,
Berkefeld
J
,
Nolte
CH
,
Bohner
G
,
Haring
HP
,
Trenkler
J
, et al.
Mechanical recanalization in basilar artery occlusion: the ENDOSTROKE study
.
Ann Neurol
.
2015
;
77
(
3
):
415
–
24
.
Google Scholar
PubMed
 
21.
Chen
ZJ
,
Li
XF
,
Liang
CY
,
Cui
L
,
Yang
LQ
,
Xia
YM
, et al.
Comparison of prior bridging intravenous thrombolysis with direct endovascular thrombectomy for anterior circulation large vessel occlusion: systematic review and meta-analysis
.
Front Neurol
.
2021
;
12
:
602370
.
Google Scholar
PubMed
 
22.
Malhotra
K
,
Liebeskind
DS
.
Collaterals in ischemic stroke
.
Brain Hemorrhages
.
2020
;
1
:
6
–
12
.
Google Scholar
 
23.
Haussen
DC
,
Bouslama
M
,
Dehkharghanii
S
,
Bowen
M
,
Faggard
J
,
Grossberg
JA
, et al.
Abstract WMP23: enhanced collaterals in patients with large vessel stroke from intracranial atherosclerosis: an automated CT perfusion-based study
.
Stroke
.
2017
;
48
(
Suppl l_1
):
AWMP23
.
Google Scholar
 
24.
Liebeskind
DS
,
Cotsonis
GA
,
Saver
JL
,
Lynn
MJ
,
Turan
TN
,
Cloft
HJ
, et al.
Collaterals dramatically alter stroke risk in intracranial atherosclerosis
.
Ann Neurol
.
2011
;
69
(
6
):
963
–
74
.
Google Scholar
PubMed
 
25.
Fischer
U
,
Kaesmacher
J
,
Mendes Pereira
V
,
Chapot
R
,
Siddiqui
AH
,
Froehler
MT
, et al.
Direct mechanical thrombectomy versus combined intravenous and mechanical thrombectomy in large-artery anterior circulation stroke: a topical review
.
Stroke
.
2017
;
48
(
10
):
2912
–
8
.
Google Scholar
PubMed
 
© 2025 S. Karger AG, Basel
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
2025
You do not currently have access to this content.